Product Details

Auro-Galantamine ER

Galantamine Hydrobromide
8 mg
ER Capsule


DIN/PIN/NPN

02425157

Manufacturer

Auro Pharma Inc.

Formulary Listing Date

2014-09-25  

Unit Price

1.2465

Amount MOH Pays

1.2465

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

N06DA04

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02266717 Reminyl ER NA NA
02398370 PMS-Galantamine ER 1.2465 1.2465
02316943 Pat-Galantamine ER 1.2465 1.2465
02339439 Mylan-Galantamine ER 1.2465 1.2465
02443015 Galantamine ER 1.2465 1.2465
02425157 Auro-Galantamine ER 1.2465 1.2465
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
347 1 year

Initial Trial: For patients with mild to moderate Alzheimer's Disease (Mini-Mental State Exam [MMSE] 10-26). Patients will be reimbursed for a period of up to 3 months after which continued treatment must be reassessed.

Network note: Maximum duration 3 months.

348 1 year

Continuation: Further reimbursement will be made available to those patients whose disease has not progressed/deteriorated while on this drug. Patients must continue to have a MMSE score of 10-26.

 

EAP Criteria

NO

Product Monograph

View Monograph